Viscover Portfolio
Preclinical Research Imaging
CommercialActive
Key Facts
About NanoPET Pharma
NanoPET Pharma is a Berlin-based diagnostic imaging company with a dual focus on preclinical research tools and clinical medical devices. Established in 2007, it has built a portfolio of innovative imaging agents under the Viscover brand for the preclinical market and commercializes devices for rheumatology diagnostics through its Xiralite subsidiary. The company acts as a B2B provider, leveraging its expertise in R&D, production, and marketing to support pharmaceutical development and improve patient care. Its strategy bridges the gap between early-stage research and clinical application in the diagnostic imaging sector.
View full company profile